Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors.

Heli Gao,Jia Dong,Wuhu Zhang,Huaxiang Xu,Longyun Ye,Hao Li,Quanxing Ni,Wenquan Wang,Liang Liu

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists（2022）

引用 1|浏览10

暂无评分

摘要

Alternating sunitinib and CAPTEM were well tolerated and associated with similar mPFS in grade 1/grade 2 PanNETs. However, larger prospective studies are required to investigate the efficacy of alternate sequential therapies for metastatic PanNET.

查看译文

关键词

alternate sequential treatment,capecitabine combined with temozolomide,pancreatic neuroendocrine tumor,sunitinib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要